Application

TERAIMMUNE

TeraImmune, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90175249
Filing Date: 09/11/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90175249
MARK INFORMATION
*MARK TERAIMMUNE
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT TERAIMMUNE
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK TeraImmune, Inc.
*MAILING ADDRESS 704 Quince Orchard Rd. Suite 160
*CITY Gaithersburg
*STATE
(Required for U.S. applicants)
Maryland
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
20878
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of autoimmune diseases and conditions; pharmaceutical preparations for the treatment of hemophilia; pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; pharmaceutical preparations for use in immunotherapy, namely, regulatory t-cell therapy.
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 040 
*IDENTIFICATION Manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of pharmaceuticals.
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Medical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy; scientific research and development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services.
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; providing a website featuring information in the medical field and in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; consulting in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy.
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Harold Milstein
ATTORNEY DOCKET NUMBER 74TV-321544
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Sheppard Mullin Richter & Hampton LLP
STREET 379 Lytton Avenue
CITY Palo Alto
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 94301
PHONE 650-815-2600
FAX 650-815-2601
EMAIL ADDRESS svtmdocketing@sheppardmullin.com
OTHER APPOINTED ATTORNEY Chelseaa Bush and the firm
CORRESPONDENCE INFORMATION
NAME Harold Milstein
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE svtmdocketing@sheppardmullin.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 4
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 1100
*TOTAL FEES PAID 1100
SIGNATURE INFORMATION
SIGNATURE /ChelseaaBush/
SIGNATORY'S NAME Chelseaa Bush
SIGNATORY'S POSITION Attorney of Record, California bar member
SIGNATORY'S PHONE NUMBER 650-815-2600
DATE SIGNED 09/11/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90175249
Filing Date: 09/11/2020

To the Commissioner for Trademarks:

MARK: TERAIMMUNE (Standard Characters, see mark)
The literal element of the mark consists of TERAIMMUNE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, TeraImmune, Inc., a corporation of Delaware, having an address of
      704 Quince Orchard Rd. Suite 160
      Gaithersburg, Maryland 20878
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for the treatment of autoimmune diseases and conditions; pharmaceutical preparations for the treatment of hemophilia; pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; pharmaceutical preparations for use in immunotherapy, namely, regulatory t-cell therapy.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 040:  Manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of pharmaceuticals.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Medical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy; scientific research and development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Providing medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; providing a website featuring information in the medical field and in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; consulting in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Harold Milstein. Other appointed attorneys are Chelseaa Bush and the firm. Harold Milstein of Sheppard Mullin Richter & Hampton LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      379 Lytton Avenue
      Palo Alto, California 94301
      United States
      650-815-2600(phone)
      650-815-2601(fax)
      svtmdocketing@sheppardmullin.com
The docket/reference number is 74TV-321544.
Harold Milstein submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Harold Milstein
       PRIMARY EMAIL FOR CORRESPONDENCE: svtmdocketing@sheppardmullin.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1100 has been submitted with the application, representing payment for 4 class(es).

Declaration

Declaration Signature

Signature: /ChelseaaBush/   Date: 09/11/2020
Signatory's Name: Chelseaa Bush
Signatory's Position: Attorney of Record, California bar member
Payment Sale Number: 90175249
Payment Accounting Date: 09/11/2020

Serial Number: 90175249
Internet Transmission Date: Fri Sep 11 17:38:08 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.X-20200911173808754
456-90175249-7503bd08e603a8feb1f57acac3f
843d0dacb4b2178192713446e8bd4813751884-D
A-38080520-20200911171221352589

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed